1. HBW Insight
  2. >>Ingredients & Safety

‘Toxic Beauty’ Documentary And The Growing Conversation Around ‘Clean’ Alternatives

 
• By Ryan Nelson

Dermatologists and industry advocates are concerned about the public’s lack of trust in science and potentially misplaced faith in “clean” beauty, which “Toxic Beauty” screenings in the US, Canada and UK likely are only reinforcing.

Shocked young couple eating popcorn and watching movie together while sitting at the cinema

“What if the next biggest chemical disaster is happening inside us?” asks a documentary, “Toxic Beauty,” that has been screening in the US, Canada and UK in recent months.

Directed by Phyllis Ellis, a field hockey Olympian turned filmmaker, and produced by White Pine Pictures, Toxic Beauty showed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By David Ridley

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By David Ridley

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

Review Suggests Advantage Of Bayer’s Iberogast Advance For Digestive Disorders

 
• By David Ridley

Bayer's Iberogast Advance's combination of six herbal ingredients may produce a synergistic effect that acts on multiple underlying issues contributing to digestive disorders like functional dyspepsia (FD) and irritable bowel syndrome (IBS), a recently published study suggests.

Allergy Ingredient Itch Warning, ACNU Final Rule Scratch Extent Of FDA Authority For Label Changes

 
• By Malcolm Spicer

Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.

More from HBW Insight

IBA Names Ooka Interim CEO; P&G, Sally Beauty Appoint Board Members – Appointments Roundup

The Independent Beauty Association announces CEO Don Frey will retire July 1 and will be replaced as interim CEO by Akemi Ooka, VP of global supply chain and sustainability resources.

Navamedic Adds OTC Naloxone With DNE Pharma Acquisition

 
• By Tom Gallen

Norway's Navamedic will move into the addiction treatment market with the acquisition of DNE Pharma, adding to its portfolio an OTC opioid overdose reversal spray.

Kenvue’s Latest Tylenol Brand Launch Steers Consumers To Dietary Supplement Section

 
• By Malcolm Spicer

The firm doesn’t hold back on linking Muscle & Joint turmeric and tamarind formulation and Muscle & Joint + Stress also containing sceletium extract to the Tylenol brand while also pointing out that neither formulation contains acetaminophen